<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/229D0677-C57B-4379-9DCB-9213DDE29E53"><gtr:id>229D0677-C57B-4379-9DCB-9213DDE29E53</gtr:id><gtr:name>Global Medical Excellence Cluster (GMEC)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Psychiatry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/229D0677-C57B-4379-9DCB-9213DDE29E53"><gtr:id>229D0677-C57B-4379-9DCB-9213DDE29E53</gtr:id><gtr:name>Global Medical Excellence Cluster (GMEC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4E80443A-E7AA-4216-9492-FC8B1A583B53"><gtr:id>4E80443A-E7AA-4216-9492-FC8B1A583B53</gtr:id><gtr:firstName>Trevor</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Robbins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5311E2FF-E2A6-419E-BA93-29A82BC923A8"><gtr:id>5311E2FF-E2A6-419E-BA93-29A82BC923A8</gtr:id><gtr:firstName>Karen</gtr:firstName><gtr:otherNames>D</gtr:otherNames><gtr:surname>Ersche</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A1E9B71F-1AD5-44B4-BAE5-6B51536B56AF"><gtr:id>A1E9B71F-1AD5-44B4-BAE5-6B51536B56AF</gtr:id><gtr:firstName>Edward</gtr:firstName><gtr:surname>Bullmore</gtr:surname><gtr:orcidId>0000-0002-8955-8283</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701497"><gtr:id>A65B11D4-75B2-46B7-9F98-EFBBB5DBC95E</gtr:id><gtr:title>Neurocognitive Endophenotypes of Stimulant Drug Dependence</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701497</gtr:grantReference><gtr:abstractText>We know that about 15% of people who try cocaine will become dependent on it within 10 years of their first use. The likelihood of developing cocaine dependence is further increased for people who have a family history of substance use disorders. Thus the addictive potential of cocaine is magnified by genetic risk factors but we currently know little about how the risks for drug dependence are inherited.

We aim to discover more about the genetic basis for cocaine dependence, by using brain imaging and cognitive testing to assess people with a clinical diagnosis of cocaine dependence and their non-dependent first degree relatives, as well as healthy normal volunteers. In this way, we aim to identify heritable traits or endophenotypes in brain organization and cognitive processing that may mediate the genetic predisposition to develop drug addiction. 

Identification of such endophenotypes would make an important contribution to understanding of drug addiction, by clarifying the distinction between those brain and cognitive abnormalities that are the effects of long-term drug abuse, versus those that represent predisposing causes of drug abuse. Delineating the neurobiological causes and effects of stimulant drug dependence will be fundamental to future development of more effective therapeutic and preventative interventions.</gtr:abstractText><gtr:technicalSummary>This project aims to define neurocognitive endophenotypes of drug addiction by examining two key aspects of brain function, reward sensitivity and inhibitory control, in currently stimulant-dependent individuals, their non-drug using siblings, and unrelated healthy controls (n=40 per group). The groups will be characterized in terms of psychopathology, cognitive function, and MRI-based measurements of brain structure and function; the fMRI paradigms are chosen to activate cortico-subcortical circuits implicated in inhibitory and reward processing. By comparing behavioural and imaging measurements between drug-dependent individuals and healthy volunteers, we will be able to test the hypothesis that reward sensitivity, inhibitory control, and the brain circuits subserving these functions, are abnormal in drug dependence. Moreover, the inclusion of a non-dependent sibling group will additionally allow us to test the hypothesis, supported by the high heritability of drug dependence syndromes, that there will be abnormalities of inhibitory and/or reward processing in first degree relatives of dependent individuals. In other words, the study is designed to test the candidacy of cognitive and imaging markers of inhibitory and reward processing as intermediate phenotypes or endophenotypes that mediate genetic risk for stimulant-dependence. The identification of such neurocognitive endophenotypes would immediately make an important contribution to biological understanding of drug-dependence syndromes by segregating those abnormalities expected in dependent individuals compared to healthy controls which are effects of long-term stimulant drug abuse (and therefore not seen in non-dependent relatives) from those which are predisposing causes of drug abuse (and therefore also seen to some extent in relatives). Clarification of this distinction between neurocognitive causes and effects of stimulant drug dependence has been difficult to achieve in clinical studies yet is fundamental to rational development of future therapeutic and preventative interventions.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>645783</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Medical Excellence Cluster (GMEC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ICCAM New drugs for addiction</gtr:description><gtr:id>EBB44288-76C6-44C1-889D-C071FDB486E1</gtr:id><gtr:impact>The ICCAM study is still ongoing, so it is a bit too early for the reporting of results.</gtr:impact><gtr:outcomeId>eYd5EuwxVDt-1</gtr:outcomeId><gtr:piContribution>The addiction endophenotype study provided valulabe pilot data and experience for the set up of the collaborative ICCAM project.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Rustat Converence on Drugs, Science and Social Realities: A Fresh Debate</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5F0E2E67-F9DD-48F3-9866-96C2E703D240</gtr:id><gtr:impact>The conference is prompted by the continuing crisis posed by substance abuse and dependency, their far-reaching consequences, and an awareness of the need for further debate and new policy initiatives. I added the findings of my MRC-funded work on the addiction vulnerability to this debate.

outreach</gtr:impact><gtr:outcomeId>F1hBwj3RVgV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European College of Neuropsychopharmacology Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B934CF93-4985-45FD-A3ED-41B76F97B973</gtr:id><gtr:impact>I presented data on the role of personality traits on addiction vulnerability.

scientific discussion</gtr:impact><gtr:outcomeId>YAbbpdeohFr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B273A80C-6D57-4D77-93B6-5A02A8E5E18A</gtr:id><gtr:impact>Pint of Science is a festival that aims to make science accessible and fun by bringing current scientific research to the welcoming atmosphere of the pub.

outreach</gtr:impact><gtr:outcomeId>nu6PyT2iaBQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.pintofscience.com/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mental Health and Learning Disability Research Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9254F231-07A8-4040-9E99-52FF227F85B1</gtr:id><gtr:impact>About 50 health care professionals attended the mental health research conference

I gave a talk on addiction vulnerability and made contact with health care professionals working in the field of addicition.</gtr:impact><gtr:outcomeId>5453cc474a4157.21489319</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5895E88D-BA77-410C-A271-AF614CB5118C</gtr:id><gtr:impact>Unfortunately, I don't have any records of numbers of people who attended this lecture.

The University of Cambridge Office for External Affairs and Communications stated in their Cambridge Scine Festival report that this lecure was extremely popular and received many positive comments.</gtr:impact><gtr:outcomeId>AFAhzwWm3QC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The science of drug addiction - an introduction to T2 Trainspotting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1DE9131C-CF45-4E03-AABE-EF70611F6416</gtr:id><gtr:impact>Introduction to drug addiction at the Cambridge Ats Picturehouse premier of the film 'T2 Trainspotting'.</gtr:impact><gtr:outcomeId>5894d3002ee0d9.90063539</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Naked Scientist Radio Show</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D5740D53-A753-4901-BE2F-0F64092454ED</gtr:id><gtr:impact>Interview regarding the relationship between cocaine and food.

outreach activity</gtr:impact><gtr:outcomeId>V1qYWAPptzm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Science Show - Cambridge 105 (Radio)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>44FD06C2-ADE5-444A-B3FB-C6EAE38D02E8</gtr:id><gtr:impact>Dr Karen Ersche tells about her research into cocaine addiction. The work investigates the finding that cocaine addiction affects some people and not others. Also, unlike other addictions, there are no substitute chemicals that can be used instead of cocaine. However Karen Ersche's research is looking at a possible candidate. The Science Show's Roger Frost asks about the use of terms such as addiction; habit and compulsive behaviour.

outreach activity</gtr:impact><gtr:outcomeId>pszLDAYUrRe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC 10'o clock News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53F0ACAE-DBCC-429D-AF25-4670A3195143</gtr:id><gtr:impact>My article in Science this year on the findings of the MRC-funded study on Neurocognitive Endopenotypes raised a lot of media interest. I gave interviews to the media around the world and the BBC showed a video clip on the Ten'o clock News program.

Several NHS Mental Health Trusts and Charities providing care for drug-dependent individuals asked me to give talks or to write about the findings in their local newsletter.</gtr:impact><gtr:outcomeId>M4P45RMVkAf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;NHS Engagement in Research&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FBB30136-BDCF-4F11-81EA-DA0A188488BA</gtr:id><gtr:impact>Regional Research Event 2012, which focuses on 
NHS engagement in research. It took place in Wyboston Lakes, Wyboston, Bedfordshire, MK44 3BA on 05 July 2012. 

My talk was on &amp;quot;Addiction Endophenotypes: A Study into the Causes and Effects of Stimulant Dependence&amp;quot;

After the talk I was approach by health care professionals working in the field of addiction, requesting advice and expressing the wish to get involved in research.</gtr:impact><gtr:outcomeId>ZKNMVJETnjM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society event organised by the European Bioinformatics Institute and held at the Cambridge Union Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>948F2014-C860-409A-B077-6786A9CA1D98</gtr:id><gtr:impact>From habit to addiction: A slippery slope is a Science and Society event organised by the European Bioinformatics Institute and held at the Cambridge Union Society.

outreach activity</gtr:impact><gtr:outcomeId>SqWT2UBGsnK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ebi.ac.uk/training/public/addiction</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2725</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NHIR Flexibility and Sustainability Funding</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>RG65249</gtr:fundingRef><gtr:id>DDDDB6DD-81EB-43E8-986A-DE69F03FBB05</gtr:id><gtr:outcomeId>eccrAxtavuV0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14922</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MHRN Resarch and Capability Funding</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>RG66986</gtr:fundingRef><gtr:id>72FD4B60-B27E-43CE-B703-583E233BB552</gtr:id><gtr:outcomeId>U6aaMcJLAWE</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12450</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>West Anglia CLRN Research Capability Funding</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>RG68442</gtr:fundingRef><gtr:id>F120B162-3DBC-4237-B70F-B8DDFECA6C67</gtr:id><gtr:outcomeId>tYXhaWe75px</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The DR-LOC is a new instrument for assessing a person's belief of 'being in control' in situations involving drug abuse. It consists of 16 item pairs presented in a forced-choice format, based on the conceptual model outlined by Rotter.</gtr:description><gtr:id>CE905B92-944E-4960-9EA1-7884EAFFBD0B</gtr:id><gtr:impact>The DR-LOC characterizes the extent to which a person believes that the additive behavior and recovery from addiction is under their personal control (internal Locus of Control) or under the influence of external circumstances (external Locus of Control).</gtr:impact><gtr:outcomeId>riV7cVfshHT</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Drug-related Locus of Control Questionnaire</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CA721B59-AA89-4B92-8B28-F0F7AAC872BC</gtr:id><gtr:title>Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>iTziDuNJXmY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBE35C19-705D-461C-80C5-BBE5305C1575</gtr:id><gtr:title>Prefrontal hypoactivity associated with impaired inhibition in stimulant-dependent individuals but evidence for hyperactivation in their unaffected siblings.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbad85e0c185baba382fb9016b50bc33"><gtr:id>dbad85e0c185baba382fb9016b50bc33</gtr:id><gtr:otherNames>Morein-Zamir S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>doi_55f9849848a52218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06223935-D0BE-4E7B-B6A0-50E581DE990B</gtr:id><gtr:title>Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5a68c48c0fdcceadf646d8bc0e59384"><gtr:id>c5a68c48c0fdcceadf646d8bc0e59384</gtr:id><gtr:otherNames>Meunier D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>PFffwYLXm8W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CC14F16-390B-407A-A981-9EE97AC34A5D</gtr:id><gtr:title>Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbad85e0c185baba382fb9016b50bc33"><gtr:id>dbad85e0c185baba382fb9016b50bc33</gtr:id><gtr:otherNames>Morein-Zamir S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>csEW3DTQsPN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BC49C9F-12A9-4683-922D-9DC411A693B5</gtr:id><gtr:title>Abnormal brain structure implicated in stimulant drug addiction.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>nj65oVVwdsd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC6959BE-B76F-49B4-B3B4-6B190AFDA819</gtr:id><gtr:title>Intoxication and Society</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ad6e833d7d01bc3cd6f97b92e2a8623"><gtr:id>7ad6e833d7d01bc3cd6f97b92e2a8623</gtr:id><gtr:otherNames>Ersche K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>9781137008329</gtr:isbn><gtr:outcomeId>cRork47AZmf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BDF8B1F-A934-43BE-B6C3-AD064BC08B3E</gtr:id><gtr:title>Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>YFkMCCyo9Vb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8F2D02E-A425-4777-8EA9-9F9D65F7023E</gtr:id><gtr:title>Using a drug-word Stroop task to differentiate recreational from dependent drug use.</gtr:title><gtr:parentPublicationTitle>CNS spectrums</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9610927d83516a48482d93eb8b24eb07"><gtr:id>9610927d83516a48482d93eb8b24eb07</gtr:id><gtr:otherNames>Smith DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1092-8529</gtr:issn><gtr:outcomeId>pm_540e159e1599a8f63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC02BA8A-0C7B-4486-A24E-3F53E0EFDFA6</gtr:id><gtr:title>Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>TUm7uFPU5DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EA06622-A9A5-438A-91C2-584229464A96</gtr:id><gtr:title>The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men.</gtr:title><gtr:parentPublicationTitle>Appetite</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-6663</gtr:issn><gtr:outcomeId>pm_15554_24_23920064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D12D089A-B7F9-486F-8657-49A06E275EDF</gtr:id><gtr:title>Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>bUffruckD2L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5251C247-EC20-4931-9E6F-C818E8411A91</gtr:id><gtr:title>Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>oxebr9XNEyV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6894B47F-5B07-4FDA-A66D-47C2E998509E</gtr:id><gtr:title>Aberrant disgust responses and immune reactivity in cocaine-dependent men.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_15554_24_24090796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D8866C1-5915-4B10-A097-153EA2C539F9</gtr:id><gtr:title>Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>pm_15554_24_22952072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>943C7204-F068-4704-AD0D-5D6DE6DB2B0D</gtr:id><gtr:title>Increased body mass index is associated with specific regional alterations in brain structure.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2cad724f994c74be18c5b3d7f854d66"><gtr:id>b2cad724f994c74be18c5b3d7f854d66</gtr:id><gtr:otherNames>Medic N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>585d671b95b549.77267976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A66EA4E1-115F-4B0C-9669-0E64A67B7846</gtr:id><gtr:title>Cocaine's appetite for fat and the consequences on body weight.</gtr:title><gtr:parentPublicationTitle>The American journal of drug and alcohol abuse</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca2cee45007f0a8ff7a5c6133ab6190d"><gtr:id>ca2cee45007f0a8ff7a5c6133ab6190d</gtr:id><gtr:otherNames>Billing L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-2990</gtr:issn><gtr:outcomeId>5453bb3a9617f0.35506863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE15D42D-4B49-44F1-BB2A-8D22404A7D2A</gtr:id><gtr:title>Decision Making, Affect, and Learning</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ad6e833d7d01bc3cd6f97b92e2a8623"><gtr:id>7ad6e833d7d01bc3cd6f97b92e2a8623</gtr:id><gtr:otherNames>Ersche K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>9780199600434</gtr:isbn><gtr:outcomeId>rHmu8srZ58E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFDC8FD0-AA21-4405-88BD-A64736B292C1</gtr:id><gtr:title>Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On.</gtr:title><gtr:parentPublicationTitle>Annual review of psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d23f7b00f22d6338172fe81219fe06a7"><gtr:id>d23f7b00f22d6338172fe81219fe06a7</gtr:id><gtr:otherNames>Everitt BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0066-4308</gtr:issn><gtr:outcomeId>585d57d96a1ca3.24717568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>596BE542-28F2-4A89-9DF3-5D2450385599</gtr:id><gtr:title>Neuroimaging in Addiction - Adinoff/Neuroimaging in Addiction</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ad6e833d7d01bc3cd6f97b92e2a8623"><gtr:id>7ad6e833d7d01bc3cd6f97b92e2a8623</gtr:id><gtr:otherNames>Ersche K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn> 978-0470660140</gtr:isbn><gtr:outcomeId>BuY6t61pp3Z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E1D729C-4ACE-41E7-B7F4-8AA10221E939</gtr:id><gtr:title>Take it or leave it: prefrontal control in recreational cocaine users.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbad85e0c185baba382fb9016b50bc33"><gtr:id>dbad85e0c185baba382fb9016b50bc33</gtr:id><gtr:otherNames>Morein-Zamir S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>56570397072832.82060107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>832C9491-FA58-4934-ACB0-8564A8E9EC1E</gtr:id><gtr:title>Neurobiological correlates of the familial risk for stimulant drug dependence.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_15554_24_23147481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B454AB5-985A-4CB8-A1D9-71297FC963A9</gtr:id><gtr:title>Cocaine dependence: a fast-track for brain ageing?</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_15554_24_22525488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>204170DE-AEA9-494D-A96A-A077D1ACFD7B</gtr:id><gtr:title>Paying attention to biased attention in drug addiction.</gtr:title><gtr:parentPublicationTitle>CNS spectrums</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1092-8529</gtr:issn><gtr:outcomeId>5453bd8026c515.74142062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B302A70-CFA6-4B93-96E6-FE524EA8922D</gtr:id><gtr:title>Overlapping decline in orbitofrontal gray matter volume related to cocaine use and body mass index.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9610927d83516a48482d93eb8b24eb07"><gtr:id>9610927d83516a48482d93eb8b24eb07</gtr:id><gtr:otherNames>Smith DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>pm_15554_24_23927455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F48D58FF-8BFB-45BC-9A97-F753BECEC040</gtr:id><gtr:title>A wavelet method for modeling and despiking motion artifacts from resting-state fMRI time series.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c744144e70a760dca9c7a5bf2de33a7"><gtr:id>4c744144e70a760dca9c7a5bf2de33a7</gtr:id><gtr:otherNames>Patel AX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_540e159e159a607c4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80D5E3A5-8FAE-4C9E-B066-5B0E7955E3D2</gtr:id><gtr:title>Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d90d99c4d1127afdf9928ecc15188f0e"><gtr:id>d90d99c4d1127afdf9928ecc15188f0e</gtr:id><gtr:otherNames>Gorodetzky H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>oH7qYsfC9A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>004A2F2B-2A4D-4D90-98F8-C06C1C7AB1E7</gtr:id><gtr:title>Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9610927d83516a48482d93eb8b24eb07"><gtr:id>9610927d83516a48482d93eb8b24eb07</gtr:id><gtr:otherNames>Smith DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>doi_15554_tp_2013_32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A232D629-BAAE-4772-9428-8214FA8E4E7C</gtr:id><gtr:title>Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>qyWGEzdvdhC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ADB0036-B05A-49B3-9784-BA3387514F2A</gtr:id><gtr:title>Signing below the dotted line: signature position as a marker of vulnerability for visuospatial processing difficulties.</gtr:title><gtr:parentPublicationTitle>Neurocase</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/948df64ae64e1ab8408920f82e59e563"><gtr:id>948df64ae64e1ab8408920f82e59e563</gtr:id><gtr:otherNames>Whitelock CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1355-4794</gtr:issn><gtr:outcomeId>5456329edffe46.57606906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF5BBA36-FFD3-4FDB-957F-EF616939786D</gtr:id><gtr:title>Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>Pj1X4u1g3tj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D0B1530-CC5E-4D03-B485-42CB0477DAB3</gtr:id><gtr:title>Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>pm_15554_24_23523373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>663B5A0D-B46F-4045-8C52-AF6B46832BD1</gtr:id><gtr:title>Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry.</gtr:title><gtr:parentPublicationTitle>Trends in cognitive sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe508993830299ec7538f494dbda4fdc"><gtr:id>fe508993830299ec7538f494dbda4fdc</gtr:id><gtr:otherNames>Robbins TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1364-6613</gtr:issn><gtr:outcomeId>pm_15554_24_22155014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>390FF5DD-CAD8-4BDF-A55C-DF95919174F6</gtr:id><gtr:title>Enhanced orbitofrontal cortex function and lack of attentional bias to cocaine cues in recreational stimulant users.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9610927d83516a48482d93eb8b24eb07"><gtr:id>9610927d83516a48482d93eb8b24eb07</gtr:id><gtr:otherNames>Smith DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_15554_24_23809860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C18EB79C-2E95-4941-8708-0AF7BAE76E91</gtr:id><gtr:title>Hierarchical modularity in human brain functional networks.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5a68c48c0fdcceadf646d8bc0e59384"><gtr:id>c5a68c48c0fdcceadf646d8bc0e59384</gtr:id><gtr:otherNames>Meunier D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-5196</gtr:issn><gtr:outcomeId>Uuq5wFaF227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70E03996-8F47-4C91-A4B9-B681D0E16B88</gtr:id><gtr:title>Disrupted iron regulation in the brain and periphery in cocaine addiction.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>58bf16483aaaf7.15167697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EC02188-8F5F-47A8-AFDB-C8045544EEE8</gtr:id><gtr:title>Who Do You Think Is in Control in Addiction? A Pilot Study on Drug-related Locus of Control Beliefs.</gtr:title><gtr:parentPublicationTitle>Addictive disorders &amp; their treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1531-5754</gtr:issn><gtr:outcomeId>pm_15554_24_23459679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AAF8923-72A5-44F7-BF17-C8E1D5B34A4B</gtr:id><gtr:title>In the face of threat: neural and endocrine correlates of impaired facial emotion recognition in cocaine dependence.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e37be242d3e6bdaf892e8e17bbfa0e"><gtr:id>c5e37be242d3e6bdaf892e8e17bbfa0e</gtr:id><gtr:otherNames>Ersche KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>565703f6a87dc5.68208573</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701497</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>